School of Medicine
Showing 1-50 of 811 Results
-
So Hee "Naomi" Ahn
Casual, Medicine - Med/Family and Community Medicine
BioNaomi is a fourth-year medical student at Seoul National University, expecting to graduate in February 2024. She earned her bachelor's degree Summa Cum Laude from Washington University in St. Louis in December 2018, majoring in Biology and minoring in Chinese Language & Culture. Although she has quite a long way to go before becoming a compassionate physician-scientist, Naomi has accumulated many years of research and clinical experience in the field of medicine, ranging from the molecular level to the population level. Her research interests lie in genomics, psychosomatic medicine, and global health.
-
Alawab Aldulimy
Contingent Employee, CV Med - Clinical Trials
Current Role at StanfordClinical Researcher
Clinical Research Coordinator -
William Alegria
Lecturer, Medicine - Med/Infectious Diseases
BioDr. Alegria is a board-certified Infectious Diseases Pharmacotherapy specialist and antimicrobial stewardship consultant with the Stanford Antimicrobial Safety and Sustainability Program. He primarily practices in the inpatient setting and is dedicated to developing targeted stewardship interventions in immunocompromised patient populations. His clinical interests include management of infections in immunocompromised hosts, antifungal pharmacotherapy, and difficult-to-treat infections.
Publications (selected)
Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead. Arya R, Zimmet AN, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
How to leverage medication use evaluations for antimicrobial stewardship goals: a primer for physicians. Prasad R, Arya R, Meng L, Holubar M, Alegria W, Zimmet AN.
Antimicrob Steward Healthc Epidemiol. 2025
Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients. Prasad R, Lu B, Veloria D, Mui E, Nelson J, Dhillon G, Deresinski S, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
No "One-Size-Fits All": chronic "Carryover" diagnoses dilute antibiotic prescribing rates for sinusitis among adults in primary and urgent care settings. Smith M, Hawkins M, Laikijrung C, Mui E, Alegria W, Leung T, Zimmet A, Ha D, Holubar M. Infect Control Hosp Epidemiol. 2024
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Lu B, Ha D, Shen S, Ferguson Toll J, Kim A, Kim S, Mui E, Deresinski S, Holubar M, Alegria W. Open Forum Infect Dis. 2024
"Electronic Phenotyping" Antimicrobials to Facilitate Outpatient Stewardship for Asymptomatic Bacteriuria and Urinary Tract Infection in Renal Transplant. Zimmet AN, Ha D, Mui E, Smith M, Hawkins M, Alegria W, Holubar M. Open Forum Infect Dis. 2024
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. Fox E, Ha D, Bounthavong M, Meng L, Mui E, Holubar M, Deresinski S, Alegria W. BMC Infect Dis. 2022
Shorter durations of antibiotic therapy in organ transplant. Alegria W, Medvedeva N, Holubar M. Curr Opin Organ Transplant. 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. Br J Haematol. 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia. Alegria W, Marini BL, Gregg KS, Bixby DL, Perissinotti A, Nagel J. J Natl Compr Canc Netw. 2022
Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit. Diep C, Meng L, Pourali S, Hitchcock MM, Alegria W, Swayngim R, Ran R, Banaei N, Deresinski S, Holubar M. Am J Health Syst Pharm. 2021 Dec
The Current State of Antifungal Stewardship in Immunocompromised Populations. Alegria W, Patel PK. J Fungi (Basel). 2021
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Holubar M, Meng L, Alegria W, Deresinski S. Infect Dis Clin North Am. 2020
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study. Hogan CA, Ebunji B, Watz N, Kapphahn K, Rigdon J, Mui E, Meng L, Alegria W, Holubar M, Deresinski S, Banaei N. J Clin Microbiol. 2020
Antimicrobial Stewardship in Cancer Patients: The Time is Now. Aitken SL, Nagel JL, Abbo L, Alegria W, Barreto JN, Dadwal S, Freifeld AG, Jain R, Pergam SA, Tverdek FP, Seo SK; Antimicrobial Stewardship in Cancer Consortium ASCC. J Natl Compr Canc Netw. 2019 -
Julia Anne Armendariz
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioI have a passion for medical education and underserved patient communities, so my job at the Palo Alto VA suits me perfectly. I have the joy of being a course director for the Stanford Internal Medicine Medical Education Elective (along with Drs. Sharmin Shekarchian and Poonam Hosamani), which is one of my very favorite things in life. The best things about being a doctor are learning new things each day, bearing witness to the human experience of illness, and taking part in relieving suffering and promoting health within my community. My hobbies include anything outdoors, working in my garden, and baking up delicious treats.
-
Lucia Aronica
Casual Employee, Medicine - Med/Stanford Prevention Research Center
BioDr. Lucia Aronica is an epigenetics and nutrigenomics scientist at Stanford University School of Medicine with over 17 years of research experience. She created Stanford's first courses in nutritional epigenetics and longevity medicine, and developed "epinutrition," a framework for optimizing gene expression through diet.
Featured in the 2024 Netflix documentary "You Are What You Eat: A Twin Experiment," Dr. Aronica is a TEDx speaker who presents to 10,000+ clinicians annually. She has published 25+ peer-reviewed papers in top journals including Cell and BMC Medicine, and secured over $1 million in competitive research funding.
Dr. Aronica received her PhD in epigenetics from the University of Vienna (2010) and conducted research at Oxford and USC. She serves on scientific advisory boards in precision health and longevity medicine. -
Yusuf Ashktorab
Contingent Employee, Medicine - Med/Nephrology
BioYusuf Ashktorab is a medical student (Class of 2028) at Howard University College of Medicine (HUCM). His journey in medicine is driven by a passion for using technology, to reduce health disparities and improve patient care.
He has contributed to projects at Stanford University, the University of California, San Francisco (UCSF), and the National Institutes of Health (NIH), focusing on topics such as predictive modeling for vaccine responses, the role of viruses in cancer development, and the use of Machine Learning and Large Language Models to diagnose Chronic Kidney Disease of Unknown Etiology (CKDu).
At HUCM, Yusuf serves as President of the Health Innovation and Technology (HIT) interest group and Vice President of Research and Technology for his class. In these roles, he is working to build a strong community centered on innovation and collaboration. -
Mukta Awasthi
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
Staff, Med/Hospital MedicineBioMukta Awasthi, MD completed her medical school training at the University of Texas Medical Branch at Galveston and Internal Medicine residency at Baylor College of Medicine in Houston, Texas. She is a board-certified academic hospitalist at the VA Palo Alto Health Care System and Clinical Assistant Professor (Affiliated) within the Stanford Division of Hospital Medicine. She has 25 years of experience in Hospital Medicine and Medical Education. She currently serves as the Medical Director of the Intermediate Intensive Care Unit at the VA Palo Alto Healthcare System. She also is the Director of the VA My Life My Story Program at the VA Palo Alto HCS. Her areas of interest include Medical Education, Quality Improvement and Narrative Medicine.
-
Adrian Matias Bacong
Postdoc Contingent, Medicine - Med/Family and Community Medicine
BioAdrian Matias Bacong, PhD, MPH is a postdoctoral research scholar within the Stanford University School of Medicine - Division of Cardiovascular Medicine. His current projects evaluate the utility of racial correction factors in cardiovascular risk algorithms, such as pooled cohort equations. This project is funded through the American Heart Association. His research also explores the intersections of social factors on health, especially among Asian Americans.
His work has been published in the Journal of Epidemiology and Community Health, Journal of Health and Social Behavior, Social Science and Medicine, the Journal of the American Heart Association, and the Journal of the American Medical Association. Dr. Bacong graduated with this PhD in Community Health Sciences from the UCLA Fielding School of Public Health in 2022 and received his MPH in Health Promotion and Behavioral Science from the San Diego State University School of Public Health in 2016.
